Bile ductular cells are simple cuboidal epithelial cells which line the short tubular biliary connections linking the bile canalicular network of the hepatocyte to the intrahepatic bile ducts located within the portal tracts of liver. Hyperplasia of these cells has been shown to be a common response in a variety of clinical and experimental forms of carcinogen and noncarcinogen-induced liver injury. Furthermore, the proliferative response exhibited in liver by """"""""oval"""""""" or bile ductular cells as a result of treatments with many hepatocarcinogens has been found to be much less orderly than the well differentiated pattern of bile ductular hyperplasia produced by noncarcinogenic treatments, such as bile duct ligation or chronic feeding of Alpha-naphthyl isothiocyanate (ANIT). Carcinogen-induced oval cell proliferation, but not well differentiated bile ductular hyperplasia, has also been demonstrated to be associated with the appearance of hepatic transitional cells possessing a morphology and functions that are intermediate between those of the hepatocyte and the bile ductular cell. The present proposal is designed to establish and then rigorously characterize novel primary and clonal cultures of well differentiated hyperplastic bile ductular cells isolated from the livers of bile duct ligated or ANIT-treated rats or hamsters, and to compare their cellular properties with those of oval and transitional cells obtained from rat liver following chronic administration of a choline-deficient diet containing 0.05% DL-ethionine. Specifically, important factors to be evaluated in the development of these cultures include substratum, basal medium conditions, regulatory substances known to influence epithelial cell differentiation or proliferation, and co-cultivation with normal adult liver hepatocytes or with fibroblasts derived from isolated cholangiofibrotic liver tissue. These cultured bile ductular and oval cells and their derivatives will then be characterized in terms of their morphology, growth kinetics, karyotype, selected enzymatic and metabolizing functions, such as gamma-glutamyl transpeptidase, leucine amino peptidase and alkaline phosphatase marker enzyme activites, and by their ability to become transformed in vitro either spontaneously or following exposures to select direct-acting or procarcinogens. Transplantation studies will also be performed in order to determine if bile ductular cells from bile duct ligated or ANIT-treated rodents can exhibit transitional hepatic cell functions when inoculated into the fat pads or spleen of host animals exhibiting severe hepatic injury.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039225-03
Application #
3178002
Study Section
Pathology B Study Section (PTHB)
Project Start
1984-07-01
Project End
1987-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Sirica, Alphonse E; Gores, Gregory J (2014) Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology 59:2397-402
Liu, Runping; Zhao, Renping; Zhou, Xiqiao et al. (2014) Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. Hepatology 60:908-18
Fingas, Christian D; Mertens, Joachim C; Razumilava, Nataliya et al. (2013) Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma. Hepatology 58:1362-74
Mertens, Joachim C; Fingas, Christian D; Christensen, John D et al. (2013) Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res 73:897-907
Campbell, Deanna J W; Dumur, Catherine I; Lamour, Nadia F et al. (2012) Novel organotypic culture model of cholangiocarcinoma progression. Hepatol Res 42:1119-30
Fingas, Christian D; Mertens, Joachim C; Razumilava, Nataliya et al. (2012) Targeting PDGFR-? in Cholangiocarcinoma. Liver Int 32:400-9
Sirica, Alphonse E (2012) The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 9:44-54
Sirica, Alphonse E; Campbell, Deanna J; Dumur, Catherine I (2011) Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 27:276-84
Fingas, Christian D; Bronk, Steven F; Werneburg, Nathan W et al. (2011) Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells. Hepatology 54:2076-88
Fingas, Christian D; Blechacz, Boris R A; Smoot, Rory L et al. (2010) A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells. Hepatology 52:550-61

Showing the most recent 10 out of 49 publications